EagleClaw Capital Management’s Sanofi SNY Stock Holding History

EagleClaw Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.45M	Sell	50,835 -550	-1%	-$25.6K	0.34%	68
2025 Q4	$2.49M	Sell	51,385 -300	-0.6%	-$14.9K	0.36%	71
2025 Q3	$2.44M	Sell	51,685 -900	-2%	-$43.4K	0.34%	72
2025 Q2	$2.54M	Buy	52,585 +6,760	+15%	+$345K	0.38%	67
2025 Q1	$2.54M	Buy	45,825 +2,175	+5%	+$118K	0.4%	70
2024 Q4	$2.11M	Buy	43,650 +375	+0.9%	+$19.1K	0.33%	76
2024 Q3	$2.49M	Buy	43,275 +925	+2%	+$49.9K	0.42%	69
2024 Q2	$2.05M	Buy	42,350 +975	+2%	+$47K	0.37%	72
2024 Q1	$2.01M	Buy	41,375 +900	+2%	+$43.9K	0.36%	74
2023 Q4	$2.01M	Buy	40,475 +7,175	+22%	+$351K	0.42%	70
2023 Q3	$1.79M	Buy	33,300 +550	+2%	+$29.3K	0.41%	72
2023 Q2	$1.77M	Buy	32,750 +1,300	+4%	+$69.9K	0.41%	71
2023 Q1	$1.71M	Buy	+31,450	New	+$1.53M	0.4%	69

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EagleClaw Capital Management's SNY Position: Q1 2026 in Review

EagleClaw Capital Management reduced its Sanofi (SNY) stake by 1.1% in Q1 2026, selling an estimated $25.6K and leaving 50,835 shares worth $2.45M. The position accounts for 0.34% of the portfolio, ranked #68.

EagleClaw Capital Management first reported a position in SNY in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.54M in Q1 2025. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

EagleClaw Capital Management held 50,835 shares of Sanofi worth $2.45M as of Q1 2026.
EagleClaw Capital Management sold 550 Sanofi shares in Q1 2026, an estimated $25.6K.
Sanofi made up 0.34% of EagleClaw Capital Management's portfolio in Q1 2026, its #68 holding.
EagleClaw Capital Management first reported a position in Sanofi in Q1 2023 and has held it in 13 quarters since.
EagleClaw Capital Management's Sanofi position peaked at $2.54M in Q1 2025.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on EagleClaw Capital Management's 13F filing for Q1 2026, filed 8 May 2026.